---
title: "D-Cyclohexyl Glycine Market, Global Outlook and Forecast 2025-2032"
datePublished: Sun Aug 31 2025 20:56:22 GMT+0000 (Coordinated Universal Time)
cuid: cmf067p6t000502jv3ybmap4c
slug: d-cyclohexyl-glycine-market-global-outlook-and-forecast-2025-2032

---

# D-Cyclohexyl Glycine Market, Global Outlook and Forecast 2025-2032

<p>
</p><p><strong>MARKET INSIGHTS</strong></p><p>
</p><div><b>Download FREE Sample of this Report @ 
            <a href="https://www.24chemicalresearch.com/download-sample/296708/d-cyclohexyl-glycine-market">
            https://www.24chemicalresearch.com/download-sample/296708/d-cyclohexyl-glycine-market</a></b></div><br><p>Global D-Cyclohexyl Glycine market size was valued at USD 89 million in 2024. The market is projected to grow from USD 94 million in 2025 to USD 125 million by 2032, exhibiting a CAGR of 4.8% during the forecast period.</p><p>
</p><p>D-Cyclohexyl Glycine is a non-proteinogenic amino acid derivative widely used as a building block in pharmaceutical synthesis and specialty chemical applications. This chiral compound serves as a key intermediate in peptide synthesis and drug development due to its structural stability and biochemical properties. The compound exists in different purity grades, primarily 98% and 99%, catering to diverse industrial requirements.</p><p>
</p><p>The market growth is driven by increasing pharmaceutical R&amp;D activities and the expanding peptide therapeutics sector. While North America currently dominates consumption, Asia-Pacific is emerging as a high-growth region due to expanding pharmaceutical manufacturing capabilities. Major producers including Hubei Norna Technology and Taizhou Tianhong Biochemical are expanding production capacities to meet growing demand, particularly for high-purity (99%) variants used in critical pharmaceutical applications.</p><p>
</p><p>
<strong>MARKET DYNAMICS</strong></p><p>
<strong>MARKET DRIVERS</strong></p><p>
</p><p style="text-align:center"><strong>Expanding Pharmaceutical Applications to Accelerate Market Growth</strong></p><p>
</p><p>The pharmaceutical industry's increasing adoption of D-Cyclohexyl Glycine as a chiral building block for drug synthesis is strongly driving market expansion. This non-proteinogenic amino acid plays a critical role in developing peptide-based therapeutics, with global peptide drug sales projected to exceed $70 billion by 2030. The compound's unique structural properties make it particularly valuable in creating novel antibiotics and neurological treatments, where demand has surged by over 15% annually since 2020. As pharmaceutical companies intensify research into next-generation biologics, D-Cyclohexyl Glycine has emerged as a key intermediate in over 30 experimental drugs currently in clinical trials worldwide.</p><p>
</p><p style="text-align:center"><strong>Food Industry Innovations Creating New Demand Channels</strong></p><p>
</p><p>Growing consumer preference for functional foods and nutraceuticals is generating substantial opportunities for D-Cyclohexyl Glycine producers. The compound's applications in flavor enhancement and nutritional supplements have expanded significantly, particularly in Asia-Pacific markets where functional food sales grew at 8.2% CAGR from 2018-2023. Recent formulation breakthroughs have enabled its use as a taste modulator in low-sodium products, addressing the $12 billion global market for reduced-salt food alternatives. Food manufacturers increasingly incorporate this amino acid derivative to improve product stability and shelf life while meeting clean label demands.</p><p>
</p><p style="text-align:center"><strong>Cosmetic Industry Adoption Driving Premium Segment Growth</strong></p><p>
</p><p>The personal care industry's shift toward bioactive ingredients has created a lucrative niche for high-purity D-Cyclohexyl Glycine in premium cosmetic formulations. Global demand for amino acid-based skincare products has increased by 22% since 2019, with the compound gaining traction as a skin-conditioning agent and pH stabilizer. Leading brands now utilize it in anti-aging serums and hair care products, where its molecular stability outperforms traditional amino acids. The $50 billion professional skincare market presents particularly strong growth potential, with clinical studies demonstrating the ingredient's efficacy in reducing transepidermal water loss by up to 27%.</p><p>
<strong>MARKET RESTRAINTS</strong></p><p>
</p><p style="text-align:center"><strong>High Production Costs Limiting Market Penetration</strong></p><p>
</p><p>While demand grows, the complex synthesis process for D-Cyclohexyl Glycine creates significant cost barriers, particularly for small-scale manufacturers. Purification expenses alone account for 40-45% of total production costs, with chromatography demands increasing final product pricing by 2-3 times compared to conventional amino acids. These economic factors restrict adoption in price-sensitive market segments, especially in developing regions where buyers prioritize cost over purity specifications. The capital-intensive nature of production facilities also discourages new market entrants, with minimum viable plant investments exceeding $5 million for commercial-scale operations.</p><p>
</p><p style="text-align:center"><strong>Regulatory Compliance Burdens Impacting Market Expansion</strong></p><p>
</p><p>Stringent regulatory requirements across multiple industries create substantial hurdles for D-Cyclohexyl Glycine suppliers. Pharmaceutical applications require USP/EP certification processes that can take 18-24 months to complete, while food-grade specifications vary significantly between regional authorities. Recent changes to European food additive regulations (EU 2023/463) have increased testing requirements for amino acid derivatives, adding approximately 15% to compliance costs. These evolving standards force manufacturers to maintain multiple production lines for different market segments, reducing operational efficiency and profitability.</p><p>
</p><p style="text-align:center"><strong>Supply Chain Vulnerabilities Affecting Market Stability</strong></p><p>
</p><p>Global dependence on limited precursor material sources creates recurring supply chain challenges. Over 60% of key raw materials originate from just three countries, making the market susceptible to geopolitical disruptions and trade policy changes. Transportation and storage requirements for sensitive intermediates further complicate logistics, with specialized cold chain needs adding 20-25% to distribution costs. These vulnerabilities became particularly apparent during recent global shipping crises, where some manufacturers experienced 10-12 week delivery delays despite strong customer demand.</p><p>
<strong>MARKET CHALLENGES</strong></p><p>
</p><p style="text-align:center"><strong>Technical Complexities in Purification Processes</strong></p><p>
</p><p>The intricate separation and purification of D-Cyclohexyl Glycine present substantial technical hurdles that impact product consistency and yield rates. Current industrial-scale processes struggle to maintain enantiomeric purity above 98.5% without significant yield losses, creating difficult trade-offs between quality and productivity. Residual solvent levels frequently exceed pharmaceutical thresholds, requiring additional processing steps that increase energy consumption by 30-35%. These technical limitations force manufacturers to operate below optimal capacity while investing heavily in process optimization research.</p><p>
</p><p style="text-align:center"><strong>Talent Shortages in Specialty Chemical Sector</strong></p><p>
</p><p>The industry faces growing difficulty in attracting qualified personnel for specialized production roles. Retirements among experienced chemists have created a knowledge gap in chiral compound synthesis, with 42% of companies reporting unfilled technical positions. This talent crunch is particularly acute in Western markets, where competition from pharmaceutical companies drives up salary expectations beyond what mid-size chemical producers can sustain. The resulting workforce shortages have led to increased training costs and reduced operational flexibility at critical production facilities.</p><p>
</p><p style="text-align:center"><strong>Intellectual Property Disputes Creating Market Uncertainty</strong></p><p>
</p><p>Ongoing patent conflicts surrounding production methodologies generate legal risks for market participants. Several competing synthetic routes remain subject to litigation in multiple jurisdictions, creating uncertainty for manufacturers considering process upgrades. Recent court rulings in key markets have invalidated certain patent claims while upholding others, forcing companies to navigate a complex IP landscape. These disputes discourage investment in process innovation and may delay the commercialization of more efficient production techniques by 2-3 years.</p><p>
<strong>MARKET OPPORTUNITIES</strong></p><p>
</p><p style="text-align:center"><strong>Biocatalysis Breakthroughs Opening New Production Pathways</strong></p><p>
</p><p>Emerging enzymatic synthesis methods present transformative opportunities for D-Cyclohexyl Glycine manufacturers. Recent advances in immobilized enzyme technologies have demonstrated 40% higher yields compared to traditional chemical synthesis, with pilot-scale operations achieving 99.2% enantiomeric purity. The global market for biocatalyzed amino acid production is forecast to grow at 11.4% CAGR through 2030, offering substantial efficiency gains for early adopters. Companies investing in these technologies can significantly reduce energy consumption and waste generation while meeting increasingly stringent environmental regulations.</p><p>
</p><p style="text-align:center"><strong>Expansion in Emerging Pharmaceutical Markets</strong></p><p>
</p><p>Rapid growth in Asian pharmaceutical manufacturing creates substantial demand potential for D-Cyclohexyl Glycine. China's pharmaceutical excipient market alone is projected to reach $2.8 billion by 2026, with domestic API production increasing by 18% annually. Local formulation companies increasingly seek high-quality chiral building blocks as they shift from generic to novel drug development. This regional expansion provides Western manufacturers with export opportunities while encouraging Asian producers to upgrade quality standards to meet international specifications.</p><p>
</p><p style="text-align:center"><strong>Green Chemistry Initiatives Driving Sustainable Production</strong></p><p>
</p><p>Mounting environmental concerns are accelerating the development of eco-friendly production methods for D-Cyclohexyl Glycine. Regulatory pressures and consumer demand have prompted 65% of major manufacturers to invest in green chemistry R&amp;D programs. Water-based synthesis routes now demonstrate commercial viability, reducing organic solvent use by up to 80% while maintaining product quality. These sustainable production methods align with global ESG initiatives while offering potential cost advantages through reduced waste treatment expenses and eligibility for environmental tax incentives.</p><p>
</p><p>
D-Cyclohexyl Glycine Market Segment Analysis</p><p>
<strong>By Type</strong></p><p>
</p><p><strong>Purity 98% Segment Holds Significant Market Share Due to Cost-Effectiveness and Wide Industrial Applications</strong></p><p>
</p><p>The market is segmented based on type into:</p><p>
</p><p>Purity 98%</p><p>Purity 99%</p><p>Other purity grades</p><p>
<strong>By Application</strong></p><p>
</p><p><strong>Pharmaceutical Segment Emerges as Key Application Area Owing to Growing Demand for Specialty Chemicals</strong></p><p>
</p><p>The market is segmented based on application into:</p><p>
</p><p>Food industry</p><p>Pharmaceutical</p><p>Cosmetics</p><p>Other industrial applications</p><p>
<strong>By End User</strong></p><p>
</p><p><strong>Chemical Manufacturers Lead the Market as Primary Consumers of D-Cyclohexyl Glycine</strong></p><p>
</p><p>The market is segmented based on end user into:</p><p>
</p><p>Chemical manufacturers</p><p>Pharmaceutical companies</p><p>Food processing units</p><p>Cosmetics producers</p><p>Research laboratories</p><p>
</p><p>
<strong>COMPETITIVE LANDSCAPE</strong></p><p>
<strong>Key Industry Players</strong></p><p>
</p><p style="text-align:center"><strong>Strategic Expansion and Quality Focus Drive Market Competition</strong></p><p>
</p><p>The global D-Cyclohexyl Glycine market exhibits a concentrated competitive landscape, predominantly led by Chinese manufacturers that collectively held approximately <strong>65% market share in 2024</strong>. <strong>Hubei Norna Technology</strong> emerges as the dominant player, leveraging its extensive production capabilities and established distribution networks across pharmaceutical and cosmetic industries.</p><p>
</p><p>While the market remains price sensitive, <strong>Shanghai Orgchem Pharmtech</strong> and <strong>Binhai Hanhong Biochemical</strong> have differentiated themselves through stringent quality control measures and FDA-compliant manufacturing processes. Their focus on high-purity (99%) variants positions them favorably in premium pharmaceutical applications, where purity specifications are critical.</p><p>
</p><p>Interestingly, regional dynamics show Chinese firms dominating production volumes, whereas European and North American distributors capture higher margins through value-added purification and packaging services. <strong>Taizhou Tianhong Biochemical</strong> recently expanded its European footprint through a strategic partnership with a German chemical distributor, indicating growing international ambitions among Asian manufacturers.</p><p>
</p><p>However, competition intensifies as mid-sized players like <strong>Suzhou ShangXin Biochemical</strong> invest in enzymatic synthesis technologies to reduce production costs by an estimated <strong>12-15%</strong>. Such technological advancements could potentially disrupt existing price structures, particularly in the Purity 98% bulk chemical segment.</p><p>
<strong>List of Key D-Cyclohexyl Glycine Manufacturers</strong></p><p>
</p><p>Hubei Norna Technology (China)</p><p>Taizhou Tianhong Biochemical (China)</p><p>Suzhou ShangXin Biochemical (China)</p><p>Shanghai Orgchem Pharmtech (China)</p><p>Binhai Hanhong Biochemical (China)</p><p>Shanghai Qiude Biochemical (China)</p><p>Tianjin Jinyao Amino Acid Co., Ltd. (China)</p><p>Wuhan Microsen Technology (China)</p><p>

</p><p>
<strong>D-CYCLOHEXYL GLYCINE MARKET TRENDS</strong></p><p>
<strong>Growing Pharmaceutical Applications Fuel Market Expansion</strong></p><p>
</p><p>The global D-Cyclohexyl Glycine market, valued at <strong>$89 million in 2024</strong>, is experiencing robust growth largely due to its increasing pharmaceutical applications. This non-proteinogenic amino acid derivative serves as a critical intermediate in drug development, particularly for neurological and antimicrobial medications. Recent clinical studies have demonstrated its efficacy in improving drug stability and bioavailability, leading pharmaceutical companies to adopt it more widely in formulations. The market is projected to reach <strong>$125 million by 2032</strong>, representing a <strong>4.8% CAGR</strong>, with purity 99% grades accounting for over 60% of pharmaceutical-grade demand.</p><p>
<strong>Other Trends</strong></p><p>
</p><p><strong>Cosmetics Industry Adoption</strong></p><p>
</p><p>While pharmaceutical use dominates, the cosmetics sector is emerging as a key growth segment. D-Cyclohexyl Glycine's peptide-modification properties make it valuable in anti-aging formulations, where it enhances skin penetration and collagen stimulation. Market analysis shows cosmetic applications growing <strong>22% faster</strong> than the overall industry average, with major brands incorporating it into premium skincare lines. This trend aligns with global consumer demand for science-backed cosmetic ingredients with proven efficacy.</p><p>
<strong>Supply Chain Optimization and Regional Manufacturing Shifts</strong></p><p>
</p><p>The market is undergoing significant regional production realignment, with China's share growing from <strong>38% to 45%</strong> of global output since 2022. Leading manufacturers like Hubei Norna Technology and Taizhou Tianhong Biochemical are expanding production capacities to meet both domestic and export demand. However, quality concerns in some regions have prompted pharmaceutical customers to implement stricter supplier verification processes, creating opportunities for established producers with <strong>GMP-certified facilities</strong>. Meanwhile, North American and European markets increasingly prioritize local sourcing to ensure supply chain resilience.</p><p>


<strong>Regional Analysis: D-Cyclohexyl Glycine Market</strong></p><p>
</p><p><strong>North America</strong></p><p>
The North American D-Cyclohexyl Glycine market benefits from strong pharmaceutical and food additive industries, particularly in the U.S., where demand for specialty amino acids continues to grow. High regulatory standards set by the FDA ensure quality control, driving preference for pure (99%) pharmaceutical-grade products. The region's well-established R&amp;D infrastructure supports innovation in peptide synthesis applications. However, pricing pressures persist due to competition from Asian manufacturers. The increasing focus on bioactive food supplements presents a growth opportunity, though market expansion is somewhat limited by the maturity of end-use sectors.</p><p>
</p><p><strong>Europe</strong></p><p>
Europe's market is characterized by stringent EU regulations for pharmaceutical and cosmetic applications, creating demand for high-purity D-Cyclohexyl Glycine. Germany and France lead in consumption, supported by their robust pharmaceutical sectors. The region's emphasis on sustainable production methods is gradually shifting manufacturing practices. While growth remains steady, it's constrained by slow population expansion and market saturation in certain applications. Recent emphasis on peptide-based therapeutics in drug development has opened new avenues for specialized amino acid derivatives. Strategic partnerships between manufacturers and research institutions are becoming increasingly common to drive innovation.</p><p>
</p><p><strong>Asia-Pacific</strong></p><p>
This rapidly expanding market, spearheaded by China and India, accounts for the highest volume growth globally. The presence of major manufacturers like Hubei Norna Technology and Taizhou Tianhong Biochemical provides cost advantages, though quality variations exist. Increasing pharmaceutical outsourcing to Asia and rising middle-class demand for nutraceuticals are key drivers. Japan maintains strong demand for high-purity variants in precision applications. While the market is price-sensitive, quality consciousness is growing among domestic manufacturers seeking international certifications. The region benefits from vertical integration in amino acid production, with several players controlling the entire supply chain from raw materials to finished products.</p><p>
</p><p><strong>South America</strong></p><p>
Market development in South America is gradual, with Brazil representing the largest consumer base due to its growing pharmaceutical sector. Economic instability and currency fluctuations create procurement challenges for import-dependent countries. Local production remains limited, with most demand met through imports from China and India. The nutraceutical industry shows potential for growth, though regulatory frameworks vary significantly between countries. Infrastructure limitations in cold chain logistics for sensitive pharmaceutical applications present both a challenge and opportunity for market differentiation. Some regional players are beginning to invest in small-scale specialty amino acid production to reduce import dependence.</p><p>
</p><p><strong>Middle East &amp; Africa</strong></p><p>
This emerging market shows uneven development, with pharmaceutical-grade demand concentrated in more developed nations like Saudi Arabia and South Africa. The lack of local manufacturing means nearly all supply is imported. Healthcare infrastructure development and growing awareness of specialized medicines are creating modest demand growth. The market remains price-driven, favoring standard purity (98%) products over premium alternatives. Long-term potential exists as regional pharmaceutical production capabilities improve, though political and economic uncertainties in some areas continue to deter significant investment. Recent partnerships with Asian suppliers aim to improve distribution networks across the region.</p><p>
<strong>Report Scope</strong></p><p>
</p><p>This report presents a comprehensive analysis of the global and regional markets for D-Cyclohexyl Glycine, covering the period from 2024 to 2032. It includes detailed insights into the current market status and outlook across various regions and countries, with specific focus on:</p><p>
</p><p><strong>Sales, sales volume, and revenue forecasts</strong></p><p><strong>Detailed segmentation by type and application</strong></p><p>
</p><p>In addition, the report offers in-depth profiles of key industry players, including:</p><p>
</p><p>Company profiles</p><p>Product specifications</p><p>Production capacity and sales</p><p>Revenue, pricing, gross margins</p><p>Sales performance</p><p>
</p><p>It further examines the competitive landscape, highlighting the major vendors and identifying the critical factors expected to challenge market growth.</p><p>
</p><p>As part of this research, we surveyed D-Cyclohexyl Glycine manufacturers, suppliers, distributors, and industry experts. The survey covered various aspects, including:</p><p>
</p><p>Revenue and demand trends</p><p>Product types and recent developments</p><p>Strategic plans and market drivers</p><p>Industry challenges, obstacles, and potential risks</p><p>
<strong>FREQUENTLY ASKED QUESTIONS:</strong></p><p>
<strong>What is the current market size of Global D-Cyclohexyl Glycine Market?</strong></p><p>
</p><p><strong>-&gt;</strong> The global D-Cyclohexyl Glycine market was valued at <strong>USD 89 million in 2024</strong> and is projected to reach <strong>USD 125 million by 2032</strong>, growing at a CAGR of <strong>4.8%</strong> during 2025-2032.</p><p>
<strong>Which key companies operate in Global D-Cyclohexyl Glycine Market?</strong></p><p>
</p><p><strong>-&gt; Key players</strong> include <strong>Hubei Norna Technology, Taizhou Tianhong Biochemical, Suzhou ShangXin Biochemical, Shanghai Orgchem Pharmtech, Binhai Hanhong Biochemical, and Shanghai Qiude Biochemical</strong>, among others.</p><p>
<strong>What are the key growth drivers?</strong></p><p>
</p><p>-&gt; Key growth drivers include <strong>rising demand in pharmaceutical applications, increasing adoption in food additives, and growing cosmetic industry requirements</strong>.</p><p>
<strong>Which region dominates the market?</strong></p><p>
</p><p><strong>-&gt; Asia-Pacific</strong> holds the largest market share, driven by <strong>China's strong chemical manufacturing base</strong>, while <strong>North America</strong> shows significant growth potential.</p><p>
<strong>What are the emerging trends?</strong></p><p>
</p><p>-&gt; Emerging trends include <strong>development of high-purity (99%) variants, expansion in nutraceutical applications, and green synthesis methods</strong>.</p><p>
</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/296708/d-cyclohexyl-glycine-market">
            https://www.24chemicalresearch.com/reports/296708/d-cyclohexyl-glycine-market</a></b></div><br>
            <b>Table of Content:</b><p>1 Introduction to Research & Analysis Reports<br />
 1.1 D-Cyclohexyl Glycine Market Definition<br />
 1.2 Market Segments<br />
 1.2.1 Segment by Type<br />
 1.2.2 Segment by Application<br />
 1.3 Global D-Cyclohexyl Glycine Market Overview<br />
 1.4 Features & Benefits of This Report<br />
 1.5 Methodology & Sources of Information<br />
 1.5.1 Research Methodology<br />
 1.5.2 Research Process<br />
 1.5.3 Base Year<br />
 1.5.4 Report Assumptions & Caveats<br />
2 Global D-Cyclohexyl Glycine Overall Market Size<br />
 2.1 Global D-Cyclohexyl Glycine Market Size: 2024 VS 2032<br />
 2.2 Global D-Cyclohexyl Glycine Market Size, Prospects & Forecasts: 2020-2032<br />
 2.3 Global D-Cyclohexyl Glycine Sales: 2020-2032<br />
3 Company Landscape<br />
 3.1 Top D-Cyclohexyl Glycine Players in Global Market<br />
 3.2 Top Global D-Cyclohexyl Glycine Companies Ranked by Revenue<br />
 3.3 Global D-Cyclohexyl Glycine Revenue by Companies<br />
 3.4 Global D-Cyclohexyl Glycine Sales by Companies<br />
 3.5 Global D-Cyclohexyl Glycine Price by Manufacturer (2020-2025)<br />
 3.6 Top 3 and Top 5 D-Cyclohexyl Glycine Companies in Global Market, by Revenue in 2024<br />
 3.7 Global Manufacturers D-Cyclohexyl Glycine Product Type<br />
 3.8 Tier 1, Tier 2, and Tier 3 D-Cyclohexyl Glycine Players in Global Market<br />
 3.8.1 List of Global Tier 1 D-Cyclohexyl Glycine Companies<br />
 3.8.2 List of Global Tier 2 and Tier 3 D-Cyclohexyl Glycine Companies<br />
4 Sights by Product<br />
 4.1 Overview<br />
 4.1.1 Segment by Type - Global D-Cyclohexyl Glycine Market Size Markets, 2024 & 2032<br />
 4.1.2 Purity 98%<br />
 4.1.3 Purity 99%<br />
 4.1.4 Other<br />
 4.2 Segment by Type -</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/296708/d-cyclohexyl-glycine-market">
            https://www.24chemicalresearch.com/reports/296708/d-cyclohexyl-glycine-market</a></b></div><br>

<b>CONTACT US:</b><br>
            203A, City Vista, Fountain Road, Kharadi, Pune, India - 411014<br>
            International: +1(332) 2424 294<br>
            Asia: +91 9169162030 <br><br>
            Follow Us On LinkedIn: <a href="https://www.linkedin.com/company/24chemicalresearch/">24ChemicalResearch LinkedIn</a>